Mohamed Algamal is a visionary life sciences leader with over 17 years of experience driving commercial excellence, market access, and patient-centered innovation across the Middle East, Africa, and global markets. As President and CEO of Hemara Bio, he leads a Dubai-based biopharmaceutical company expanding access to innovative therapies in hematology, rare diseases, and oncology.

Previously, he held senior leadership roles at Emmaus Life Sciences, Baxter Oncology, Servier, Taiba, and Amgen, achieving market leadership and building high-performing teams. Recognized for his inspirational leadership, Mohamed has launched transformative therapies and shaped sustainable healthcare models worldwide.

His career exemplifies how vision, collaboration, and purpose can transform patient care and access globally.